Changes in the geometry and robustness of diffusion tensor imaging networks: Secondary analysis from a randomized controlled trial of young autistic children receiving an umbilical cord blood infusion

Anish K. Simhal, Kimberly L. H. Carpenter, Joanne Kurtzberg, Allen W. Song, Allen Tannenbaum, Lijia Zhang, Guillermo Sapiro, Géraldine DawsonFrontiers in Psychiatry 2022 · DOI

Abstract

Diffusion tensor imaging (DTI) has been used as an outcome measure in clinical trials for several psychiatric disorders but has rarely been explored in autism clinical trials. This is despite a large body of research suggesting altered white matter structure in autistic individuals. The current study is a secondary analysis of changes in white matter connectivity from a double-blind placebo-control trial of a single intravenous cord blood infusion in 2-7-year-old autistic children. Both clinical assessments and DTI were collected at baseline and 6 months after infusion. This study used two measures of white matter connectivity: change in node-to-node connectivity as measured through DTI streamlines and a novel measure of feedback network connectivity, Ollivier-Ricci curvature (ORC). ORC is a network measure which considers both local and global connectivity to assess the robustness of any given pathway. Using both the streamline and ORC analyses, we found reorganization of white matter pathways in predominantly frontal and temporal brain networks in autistic children who received umbilical cord blood treatment versus those who received a placebo. By looking at changes in network robustness, this study examined not only the direct, physical changes in connectivity, but changes with respect to the whole brain network. Together, these results suggest the use of DTI and ORC should be further explored as a potential biomarker in future autism clinical trials. These results, however, should not be interpreted as evidence for the efficacy of cord blood for improving clinical outcomes in autism.

Introduction

Clinical trials for autism spectrum disorder (ASD) are frequently complicated by high placebo response rates, largely due to the reliance on subjective behavioral assessments. To improve the reliability of these trials, there is an urgent need for objective biological biomarkers that can demonstrate "target engagement"—evidence that a treatment is physically altering brain structure or function. While previous research has identified altered white matter connectivity in autistic individuals, standard imaging techniques often lack the sensitivity to detect subtle changes in network architecture. This study explores the utility of Diffusion Tensor Imaging (DTI) and a novel geometric measure, Ollivier-Ricci Curvature (ORC), as potential biomarkers in a clinical trial context.

Methodology: Beyond Simple Connectivity

This study performed a secondary analysis of data from a Phase II randomized, double-blind, placebo-controlled trial (NCT02847182) involving 165 children with ASD (aged 2–7 years). Participants were randomized to receive either a single intravenous infusion of umbilical cord blood or a placebo. Brain imaging was conducted at baseline and six months post-infusion using 3.0T MRI.

The researchers employed two primary metrics to evaluate white matter changes:

  1. Streamline Counts: A traditional DTI measure quantifying the physical number of axonal bundles between 83 brain regions.
  2. Ollivier-Ricci Curvature (ORC): A novel graph-theory metric that assesses network robustness.
Illustration of ORC on exemplar networks. (A) Positive ORC indicates multiple pathways (robustness). (B) Negative ORC indicates a single pathway (fragility).

ORC provides a more nuanced view of brain connectivity than streamlines alone. Positive ORC suggests a "hub-like" architecture with redundant pathways, meaning the network can withstand small perturbations. Conversely, negative ORC indicates a "tree-like" or fragile architecture where information flow is easily disrupted by a single connection failure.

Results and Key Findings

The analysis revealed significant reorganization of white matter pathways in children who received the cord blood treatment compared to the placebo group. These changes were predominantly localized in frontal and temporal networks, areas critical for social communication and cognitive control.

The Impact of Intellectual Ability

A key finding was that the brain's structural response to the infusion was highly dependent on the child's baseline Non-Verbal IQ (NVIQ):

  • NVIQ ≥ 70: Children in this group showed reorganization primarily in the left hemisphere. Specifically, there was a significant increase in ORC (robustness) between the cuneus and fusiform gyrus (visual/face processing) and between the caudal anterior cingulate cortex (ACC) and the inferior frontal gyrus (IFG).
  • NVIQ < 70: Children in this group exhibited changes predominantly in the right hemisphere, including decreased streamlines between the right dorsolateral prefrontal cortex (dlPFC) and the IFG.

Targeting the "Social Brain"

The observed structural shifts were concentrated in frontolimbic circuits and visual processing areas known to be involved in social communication, language, and face processing—core domains of difference in autism.

Discussion: Biomarkers vs. Clinical Efficacy

Notably, the study did not find a direct correlation between these imaging changes and improvements on standard behavioral scales (e.g., VABS-3, PDD-BI). This suggests that structural brain reorganization may occur independently of, or precede, detectable behavioral shifts.

It is important to emphasize that these results do not constitute evidence for the clinical efficacy of cord blood infusions in treating autism. Instead, they highlight the potential of DTI and ORC as "stratification biomarkers." By assessing a child's baseline brain robustness, researchers might be able to predict who is most likely to respond to a specific intervention, allowing for more targeted and efficient clinical trials in the future.

Conclusion

The integration of advanced network geometry measures like ORC into clinical trial protocols offers a promising path toward objective assessment in ASD research. While further validation is required, these metrics provide a window into the brain's structural plasticity and its response to potential therapeutic interventions.

Summary updated

Abstract

Diffusion tensor imaging (DTI) has been used as an outcome measure in clinical trials for several psychiatric disorders but has rarely been explored in autism clinical trials. This is despite a large body of research suggesting altered white matter structure in autistic individuals. The current study is a secondary analysis of changes in white matter connectivity from a double-blind placebo-control trial of a single intravenous cord blood infusion in 2-7-year-old autistic children (1). Both clinical assessments and DTI were collected at baseline and 6 months after infusion. This study used two measures of white matter connectivity: change in node-to-node connectivity as measured through DTI streamlines and a novel measure of feedback network connectivity, Ollivier-Ricci curvature (ORC). ORC is a network measure which considers both local and global connectivity to assess the robustness of any given pathway. Using both the streamline and ORC analyses, we found reorganization of white matter pathways in predominantly frontal and temporal brain networks in autistic children who received umbilical cord blood treatment versus those who received a placebo. By looking at changes in network robustness, this study examined not only the direct, physical changes in connectivity, but changes with respect to the whole brain network. Together, these results suggest the use of DTI and ORC should be further explored as a potential biomarker in future autism clinical trials. These results, however, should not be interpreted as evidence for the efficacy of cord blood for improving clinical outcomes in autism. This paper presents a secondary analysis using data from a clinical trial that was prospectively registered with ClinicalTrials.gov(NCT02847182).
BibTeX
@inproceedings{simhal2022changes,
  author = {Anish K. Simhal and Kimberly L. H. Carpenter and Joanne Kurtzberg and Allen W. Song and Allen Tannenbaum and Lijia Zhang and Guillermo Sapiro and Géraldine Dawson},
  title = {{Changes in the geometry and robustness of diffusion tensor imaging networks: Secondary analysis from a randomized controlled trial of young autistic children receiving an umbilical cord blood infusion}},
  booktitle = {Frontiers in Psychiatry},
  year = {2022},
  doi = {10.3389/fpsyt.2022.1026279},
}
Figure